Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic HCV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00983853
What this trial is testing

Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

Who this might be right for
Hepatitis CHIV Infections
Vertex Pharmaceuticals Incorporated 62
Testing effectiveness (Phase 2)Study completedNCT00097435
What this trial is testing

Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Human Genome Sciences Inc. 115
Large-scale testing (Phase 3)Study completedNCT00703118
What this trial is testing

A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment

Who this might be right for
Hepatitis C, Chronic
Tibotec BVBA 663
Testing effectiveness (Phase 2)Study completedNCT00991289
What this trial is testing

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Who this might be right for
HIV InfectionHepatitis C Infection
National Institute of Allergy and Infectious Diseases (NIAID) 68
Early research (Phase 1)Study completedNCT00359463
What this trial is testing

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 33
Not applicableStudy completedNCT02452814
What this trial is testing

Long Term Extension Study is Designed to Monitor Long-Term Efficacy and Safety of Miravirsen Sodium in Combination With Telaprevir and Ribavirin in Subjects With Chronic Hepatitis C Virus Genotype 1 Infection

Who this might be right for
HCV
Hoffmann-La Roche 8
Not applicableUnknownNCT01178749
What this trial is testing

Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin Treatments

Who this might be right for
Chronic Hepatitis C
National Taiwan University Hospital 390
Large-scale testing (Phase 3)Study completedNCT00200343
What this trial is testing

Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Tanabe Pharma Corporation 596
Post-approval studies (Phase 4)Study completedNCT03365635
What this trial is testing

Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C

Who this might be right for
Hepatitis CHemodialysisNosocomial Infection
University of Pennsylvania 6
Large-scale testing (Phase 3)Study completedNCT02021643
What this trial is testing

Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection

Who this might be right for
Chronic HCV Infection
Gilead Sciences 687
Post-approval studies (Phase 4)Study completedNCT02498015
What this trial is testing

A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection

Who this might be right for
Hepatitis C, Chronic
Kirby Institute 87
Large-scale testing (Phase 3)Study completedNCT01263860
What this trial is testing

Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-6 Patients

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 242
Post-approval studies (Phase 4)Study completedNCT02214420
What this trial is testing

SMV + SOF With/Without RBV for IFN-II Patients With CHC

Who this might be right for
Hepatitis C
SC Liver Research Consortium, LLC 24
Not applicableStudy completedNCT02581189
What this trial is testing

Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada

Who this might be right for
Chronic Hepatitis C
AbbVie 565
Post-approval studies (Phase 4)Ended earlyNCT02120274
What this trial is testing

Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C

Who this might be right for
RNA Virus InfectionsFlaviviridae InfectionsHepatitis C+1 more
Federal University of São Paulo 85
Testing effectiveness (Phase 2)Study completedNCT01140997
What this trial is testing

Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Xiamen Amoytop Biotech Co., Ltd. 211
Not applicableStudy completedNCT03155906
What this trial is testing

Integrated Treatment of Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, ChronicOpioid Dependence, on Agonist Therapy
Haukeland University Hospital 298
Testing effectiveness (Phase 2)Study completedNCT01687257
What this trial is testing

Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation

Who this might be right for
Hepatitis CCirrhosisPortal Hypertension+1 more
Gilead Sciences 50
Post-approval studies (Phase 4)Study completedNCT00926614
What this trial is testing

Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba

Who this might be right for
Hepatitis c
Brooke Army Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT01717326
What this trial is testing

The Combination Regimen Grazoprevir (MK-5172) and Elbasvir (MK-8742) ± Ribavirin in Participants With Chronic Hepatitis C (MK-5172-035)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 573
Next Page